The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A Prospective Randomized Comparative Trial Showing That Omeprazole Prevents Rebleeding in Patients With Bleeding Peptic Ulcer After Successful Endoscopic Therapy
Abstract
BACKGROUND: A blood clot in a peptic ulcer is unstable in a low pH environment. The use of omeprazole may prevent rebleeding by elevating intragastric pH in patients with bleeding peptic ulcer after hemostasis has been achieved. OBJECTIVES: To assess the influence of using omeprazole and cimetidine on 24-hour intragastric pH and to determine their ability to prevent rebleeding after having achieved initial hemostasis in patients with active bleeding or nonbleeding visible vessels. METHODS: One hundred patients with bleeding peptic ulcers who had obtained initial hemostasis were enrolled in this randomized comparative trial. In the cimetidine group (n = 50), a 300-mg intravenous bolus of cimetidine was given, followed by a 1200-mg continuous infusion daily for 3 days. Thereafter, 400 mg of cimetidine was given orally twice daily for 2 months. In the omeprazole group (n = 50), a 40-mg intravenous bolus of omeprazole was given, followed by 160 mg of continuous infusion daily for 3 days. Thereafter, 20 mg of omeprazole was given orally once daily for 2 months. A pH meter was inserted in each patient's fundus under fluoroscopic guidance after the intravenous bolus of cimetidine or omeprazole had been administered. RESULTS: The stigmata of recent hemorrhage before endoscopic therapy in the omeprazole and cimetidine groups were, respectively, spurting (9 vs 12), oozing (4 vs 9), and nonbleeding visible vessel (37 vs 29) (P > .05). The duration of intragastric pH higher than 6.0 was longer in the omeprazole group (mean [+/- SD], 84.4% +/- 22.9%) than that of the cimetidine group (mean [+/- SD], 53.5% +/- 32.3%) (P < .001). Rebleeding occurred in 2 patients (4%) in the omeprazole group and in 12 patients (24%) in the cimetidine group by day 14 after enrollment (P = .004). There was a tendency for patients in the omeprazole group to require less blood transfusion (median, 0 mL; range, 0-2500 mL) than those in the cimetidine group (median, 0 mL; range, 0-5000 mL) (P = .08). The hospital stay and number of operations and mortality rate were similar between both groups. CONCLUSIONS: The use of omeprazole is more effective than cimetidine in increasing intragastric pH and reducing rebleeding episodes in patients with bleeding peptic ulcers after successful endoscopic therapy. This suggests that omeprazole should be used routinely after successful endoscopic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis
Cook, D. J., Guyatt, G. H., Salena, B. J., & Laine, L. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91793-4 · Cited by 733
Effect of acid and pepsin on blood coagulation and platelet aggregation
Green, F. W., Kaplan, M. M., Curtis, L. E., & Levine, P. H. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90352-9 · Cited by 504
Omeprazole: An Updated Review of its Pharmacology and Therapeutic Use in Acid-Related Disorders
McTavish, D., Buckley, M. M.-T., & Heel, R. C. (1991) · Drugs · doi:10.2165/00003495-199142010-00008 · Cited by 282
Daneshmend, T. K., Hawkey, C. J., Langman, M. J., Logan, R. F., Long, R. G., & Walt, R. P. (1992) · BMJ · doi:10.1136/bmj.304.6820.143 · Cited by 242
Clot lysis by gastric juice: an in vitro study.
Patchett, S. E., Enright, H., Afdhal, N. H., O'Connell, W., & O’Donoghue, D. P. (1989) · Gut · doi:10.1136/gut.30.12.1704 · Cited by 147
Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers
Laine, L. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91154-x · Cited by 134
Lanas, A., Artal, A., Blas, J. M., et al. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199509000-00008 · Cited by 102
Villanueva, C., Balanzo, J. M., Torras, X., et al. (1995) · Endoscopy · doi:10.1055/s-2007-1005698 · Cited by 79
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
Merki, H. S., Witzel, L., Kaufman, D., Kempf, M., Neumann, J., Röhmel, J., & Walt, R. P. (1988) · Gut · doi:10.1136/gut.29.4.453 · Cited by 60
Non-Bleeding Visible Vessel Treatment: Perendoscopic Injection Therapy versus Omeprazole Infusion
Grosso, C., Rossi, A., Gambitta, P., et al. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509101593 · Cited by 36
Cited by
Barkun, A. N., Bardou, M., Kuipers, E. J., Sung, J., Hunt, R. H., Martel, M., Sinclair, P., & for the International Consensus Upper Gastrointestinal Bleeding Conference Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00009 · Cited by 1,163
Lau, J. Y. W., Sung, J. J. Y., Lee, K. K. C., Yung, M.-Y., Wong, S. K. H., Wu, J. C. Y., Chan, F. K. L., Ng, E. K. W., You, J. H. S., Lee, C. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430501 · Cited by 699
ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding
Laine, L., Barkun, A. N., Saltzman, J. R., Martel, M., & Leontiadis, G. I. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001245 · Cited by 646
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
Barkun, A., Bardou, M., Marshall, J. K., & for the Nonvariceal Upper GI Bleeding Consensus Conference Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00012 · Cited by 544
van Leerdam, M. E., Vreeburg, E. M., Rauws, E. A. J., Geraedts, A. A. M., Tijssen, J. G. P., Reitsma, J. B., & Tytgat, G. N. J. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07517.x · Cited by 508
Lau, J. Y. W., Sung, J. J. Y., Lam, Y.-H., Chan, A. C. W., Ng, E. K. W., Lee, D. W. H., Chan, F. K. L., Suen, R. C. Y., & Chung, S. C. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401002 · Cited by 507
Laine, L., & McQuaid, K. R. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.016 · Cited by 387
Barkun, A., Sabbah, S., Enns, R., Armstrong, D., Gregor, J., Fedorak, R. N. N., Rahme, E., Toubouti, Y., Martel, M., Chiba, N., et al. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30272.x · Cited by 376
Wolfe, M. M., & Sachs, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70004-7 · Cited by 354
Non-variceal upper gastrointestinal haemorrhage: guidelines
(2002) · Gut · doi:10.1136/gut.51.suppl_4.iv1 · Cited by 261
Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding
Bardou, M., Toubouti, Y., Benhaberou‐Brun, D., Rahme, E., & Barkun, A. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02391.x · Cited by 132
Metadata
- Authors
- Lin, H.-J., Lo, W.-C., Lee, F.-Y., Perng, C.-L., & Tseng, G.-Y.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1998-01-12
- Volume
- 158
- Issue
- 1
- Pages
- 54
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2048086356
- Cited by
- 260
- References
- 10
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.